Genetic heterogeneity in response to adenovirus gene therapy
BACKGROUND: After intravenous delivery of the adenoviral vector into rats or mice, 95–99% of the encoded protein is produced in the hepatocytes. We observed, as have others, that the early expression levels of the vector encoded protein vary, greatly, within a species, from one animal strain to anot...
Gardado en:
| Publicado en: | BMC Mol Biol |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2003
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC155537/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12697054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2199-4-4 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|